ÂÜÀòÂÒÂ×

Bradley Hardiman is an experienced professional in business development and investment, currently serving as a Visiting Business Fellow at InnovationRCA since February 2012 and an Investor at Spex Capital since April 2021. In addition, Bradley holds the position of Senior Director, Ventures - Business Development at Astellas Pharma Europe, having transitioned there as of August 2023 after a successful tenure in various roles within the company, including Scouting & Transaction and Innovation Management. Previous experience includes partnering at Adrenaline Capital Partners, serving as Managing Partner for Future Care Capital, and holding key investment roles at Cambridge Enterprise, where significant growth was achieved in the university's investment portfolio. Educational qualifications include an MBA from Bayes Business School, an MSc in Molecular Biochemistry from the University of Cambridge, and a BSc in Medical Biochemistry from Brunel University of London.